IKT-001

IKT-001 · Inhibikase Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IKT-001, covering 2026-01-27 to 2026-01-27. Get the full timeline:

Most recent: Clinical Trial Update: An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH) [Phase 3]